| Literature DB >> 21112505 |
Janusz A Jankowski1, Patricia A Hooper.
Abstract
Esophageal adenocarcinoma is increasing in incidence. The main risk factor is the premalignant condition of Barrett's esophagus. There is great interest in chemoprevention to prevent or slow malignant transformation. There are many agents proposed as playing a role in chemoprevention; however, none is licensed for this role as yet. Aspirin possesses many favorable qualities for chemoprevention and is the focus of the largest randomized control trial in this field.Entities:
Mesh：
Substances：
Year: 2011 PMID： 21112505 DOI： 10.1016/j.giec.2010.09.005
Source DB: PubMed Journal: Gastrointest Endosc Clin N Am ISSN： 1052-5157